Atle Fund Management AB

Position in GILD — Gilead Sciences, Inc.

CIK 1381843 STOCKHOLM, V7

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$5,829,580

-$855,580 QoQ

Shares Held

46,142

-3.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

#545

of 2,266 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $117,376,751 across 6 Drug Manufacturers - General names. GILD ranks #6 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	29,821	$35,768,205
2	MRK	Merck & Co., Inc.	189,357	$24,332,374
3	JNJ	Johnson & Johnson	85,425	$21,695,387
4	ABBV	AbbVie Inc.	64,325	$16,186,743
5	BIIB	Biogen Inc.	62,781	$13,564,462
6	GILD	Gilead Sciences, Inc. This page	46,142	$5,829,580

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,829,580	46,142	-3.8%	Shares	Sole	2026-07-24
2026-03-31	$6,685,160	47,967	-5.6%	Shares	Sole	2026-05-11
2025-12-31	$6,234,701	50,796	-35.0%	Shares	Sole	2026-02-06
2025-09-30	$921,159	78,169	+6.8%	Shares	Sole	2025-11-04
2025-06-30	$8,111,803	73,165	-5.0%	Shares	Sole	2025-07-14
2025-03-31	$8,627,625	76,998	+48.1%	Shares	Sole	2025-05-05
2024-03-31	$3,809,000	52,000	-47.5%	Shares	Sole	2024-04-25
2023-12-31	$8,017,883	98,974	+62.9%	Shares	Sole	2024-01-30
2022-12-31	$5,216,246	60,760	-42.1%	Shares	Sole	2023-02-14
2022-09-30	$6,477,450	105,000	+81.0%	Shares	Sole	2022-10-21
2022-06-30	$3,584,980	58,000	-40.8%	Shares	Sole	2022-07-08
2022-03-31	$5,826,100	98,000	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.